已收盘 07-02 16:00:00 美东时间
-0.390
-2.92%
Viant Technology CFO Larry Madden sells 33,333 shares for $405,894 Viant CFO Larry Madden sold 33,333 shares of Class A common stock on June 5-8. Sales priced at about $12.24 and $12.1 per share. Post-transaction direct holdings fell to 484,531 shares. Disclaimer: This news brief was created by Publ
06-09 08:23
Viant COO Christopher Vanderhook disposes of USD 135,302 common shares Viant Technology Chief Operating Officer Christopher Vanderhook reported Capital V LLC exchanged 12,500 Class B Units into 12,500 Class A shares on May 19, cancelling 12,500 Class B common shares. Capital V LLC then sold 12,500 C
05-22 09:35
Viant CEO, Chairman Timothy Vanderhook disposes of USD 162,710 common shares Viant Technology CEO and Chairman Timothy Vanderhook reported sales of 12,500 shares of Class A common stock via Capital V LLC between May 19 and May 21. The sales were executed at weighted average prices of USD 10.89, USD
05-22 09:35
Capital V disposes of Viant Technology common shares worth $403,063.33 Capital V, a 10% owner of Viant Technology Inc., sold 37,500 shares of Class A common stock in transactions dated May 19-21. The sales were reported at weighted average prices of $10.89, $10.6, and $10.79. Capital V also exchange
05-22 09:34
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Viant业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **Q1 2026核心财务指标表现:** - **营收**:8,850万美元,同比增长25%,超出指导预期上限3% - **Contribution ex-TAC**:5,030万美元,同比增长18%,高于指导预期中位数 - **调整后EBITDA**:980万美元,同比增长81%,超出指导预期上限3% - **Non-GAAP净利润**:560万美元,同比增长近100%(去年同期280万美元) - **Non-GAAP每股收益**:0.09美元,同比增长125%(去年同期0.
05-13 12:28
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
B. Riley Securities analyst Zach Cummins maintains Viant Technology (NASDAQ:DSP) with a Buy and raises the price target from $17 to $18.
05-12 23:49
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Sotera Health (SHC) on Tuesday said it appointed Alton Shader as CEO, effective May 26, as part of a planned leadership transition. Shader, currently CEO of Viant Medical, will also join the company’s...
05-05 20:18
Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of DirectorsCLEVELAND,
05-05 19:25